Endomucin restores depleted endothelial glycocalyx in the retinas of streptozotocin-induced diabetic rats
- PMID: 31545913
- DOI: 10.1096/fj.201901161R
Endomucin restores depleted endothelial glycocalyx in the retinas of streptozotocin-induced diabetic rats
Abstract
Endothelial glycocalyx plays a significant role in the development and progression of diabetic complications. Endomucin (EMCN) is an anti-inflammatory membrane glycoprotein that is mainly expressed in venous and capillary endothelial cells. However, the function of EMCN in diabetic retinopathy (DR) progression is still completely unknown. We first investigated the change of EMCN expression in the retina and human retinal microvascular endothelial cells. We then overexpressed EMCN in the retina with adeno-associated virus and induced DR with streptozotocin (STZ). We analyzed EMCN's effect on the integrity of endothelial glycocalyx under conditions of DR. Furthermore, we investigated EMCN's protective effect against inflammation and blood-retinal barrier (BRB) destruction. We found that EMCN is specifically expressed in retinal endothelial cells and that its levels are decreased during hyperglycemia in vitro and in vivo. Overexpression of EMCN can restore the retinal endothelial glycocalyx of STZ-induced diabetic rats. Furthermore, EMCN overexpression can decrease leukocyte-endothelial adhesion to ameliorate inflammation and stabilize the BRB to inhibit vessel leakage in rats with DR. EMCN may protect patients with diabetes from retinal vascular degeneration by restoring the endothelial glycocalyx. EMCN may thus represent a novel therapeutic strategy for DR because it targets endothelial glycocalyx degradation associated with this disease.-Niu, T., Zhao, M., Jiang, Y., Xing, X., Shi, X., Cheng, L., Jin, H., Liu, K. Endomucin restores depleted endothelial glycocalyx in the retinas of streptozotocin-induced diabetic rats.
Keywords: blood-retinal barrier; diabetic retinopathy; inflammation.
Similar articles
-
Endothelial glycocalyx in retina, hyperglycemia, and diabetic retinopathy.Am J Physiol Cell Physiol. 2023 May 1;324(5):C1061-C1077. doi: 10.1152/ajpcell.00188.2022. Epub 2023 Mar 20. Am J Physiol Cell Physiol. 2023. PMID: 36939202 Free PMC article. Review.
-
Endomucin selectively regulates vascular endothelial growth factor receptor-2 endocytosis through its interaction with AP2.Cell Commun Signal. 2024 Apr 11;22(1):225. doi: 10.1186/s12964-024-01606-w. Cell Commun Signal. 2024. PMID: 38605348 Free PMC article.
-
Hyperglycemia-induced effects on glycocalyx components in the retina.Exp Eye Res. 2021 Dec;213:108846. doi: 10.1016/j.exer.2021.108846. Epub 2021 Nov 18. Exp Eye Res. 2021. PMID: 34801534 Free PMC article.
-
Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.Cell Physiol Biochem. 2018;45(2):505-522. doi: 10.1159/000487029. Epub 2018 Jan 25. Cell Physiol Biochem. 2018. PMID: 29402864
-
Modulation of endothelial glycocalyx structure under inflammatory conditions.Mediators Inflamm. 2014;2014:694312. doi: 10.1155/2014/694312. Epub 2014 Apr 3. Mediators Inflamm. 2014. PMID: 24803742 Free PMC article. Review.
Cited by
-
Porous Se@SiO2 nanospheres alleviate diabetic retinopathy by inhibiting excess lipid peroxidation and inflammation.Mol Med. 2024 Feb 6;30(1):24. doi: 10.1186/s10020-024-00785-z. Mol Med. 2024. PMID: 38321393 Free PMC article.
-
Endothelial glycocalyx in retina, hyperglycemia, and diabetic retinopathy.Am J Physiol Cell Physiol. 2023 May 1;324(5):C1061-C1077. doi: 10.1152/ajpcell.00188.2022. Epub 2023 Mar 20. Am J Physiol Cell Physiol. 2023. PMID: 36939202 Free PMC article. Review.
-
The Endothelial Glycocalyx and Retinal Hemodynamics.Pathophysiology. 2022 Dec 17;29(4):663-677. doi: 10.3390/pathophysiology29040052. Pathophysiology. 2022. PMID: 36548208 Free PMC article.
-
Loss of endothelial EMCN drives tumor lung metastasis through the premetastatic niche.J Transl Med. 2022 Oct 2;20(1):446. doi: 10.1186/s12967-022-03649-4. J Transl Med. 2022. PMID: 36184589 Free PMC article.
-
The Glomerular Endothelium Restricts Albumin Filtration.Front Med (Lausanne). 2021 Nov 29;8:766689. doi: 10.3389/fmed.2021.766689. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34912827 Free PMC article. Review.
References
REFERENCES
-
- Leasher, J. L., Bourne, R. R., Flaxman, S. R., Jonas, J. B., Keeffe, J., Naidoo, K., Pesudovs, K., Price, H., White, R. A., Wong, T. Y., Resnikoff, S., and Taylor, H. R.; Vision Loss Expert Group of the Global Burden of Disease Study. (2016) Global estimates on the number of people blind or visually impaired by diabetic retinopathy: a meta-analysis from 1990 to 2010. Diabetes Care 39, 1643-1649; erratum: 2096
-
- El-Asrar, A. M. (2012) Role of inflammation in the pathogenesis of diabetic retinopathy. Middle East Afr. J. Ophthalmol. 19, 70-74
-
- Park, D. Y., Lee, J., Kim, J., Kim, K., Hong, S., Han, S., Kubota, Y., Augustin, H. G., Ding, L., Kim, J. W., Kim, H., He, Y., Adams, R. H., and Koh, G. Y. (2017) Plastic roles of pericytes in the blood-retinal barrier. Nat. Commun. 8, 15296
-
- Joussen, A. M., Murata, T., Tsujikawa, A., Kirchhof, B., Bursell, S. E., and Adamis, A. P. (2001) Leukocyte-mediated endothelial cell injury and death in the diabetic retina. Am. J. Pathol. 158, 147-152
-
- Joussen, A. M., Poulaki, V., Le, M. L., Koizumi, K., Esser, C., Janicki, H., Schraermeyer, U., Kociok, N., Fauser, S., Kirchhof, B., Kern, T. S., and Adamis, A. P. (2004) A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J. 18, 1450-1452
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources